Hepatocellular carcinoma: Current management and future trends
- 1 November 2004
- journal article
- review article
- Published by Elsevier in Gastroenterology
- Vol. 127 (5) , S218-S224
- https://doi.org/10.1053/j.gastro.2004.09.036
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Molecular-based prediction of early recurrence in hepatocellular carcinomaJournal of Hepatology, 2004
- A phase III study of doxorubicin (A) versus cisplatin (P)/ interferonα-2b (I)/ doxorubicin (A)/ fluorouracil (F) combination chemotherapy (PIAF) for inoperable hepatocellular carcinoma (HCC)Journal of Clinical Oncology, 2004
- Hepatocellular carcinomaPublished by Elsevier ,2003
- Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survivalHepatology, 2003
- Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: Meta-Analysis of Randomized Controlled TrialsRadiology, 2002
- Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trialThe Lancet, 2002
- Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL ConferenceJournal of Hepatology, 2001
- Appraisal of transplantation for malignant tumours of the liver with special reference to early stage hepatocellular carcinomaEuropean Journal of Surgical Oncology, 1998
- Hepatic Resection Versus Transplantation for Hepatocellular CarcinomaAnnals of Surgery, 1991
- Natural history of hepatocellular carcinoma and prognosis in relation to treatment study of 850 patientsCancer, 1985